logo
AAT Bioquest

Sodium channel protein type V alpha subunit Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
6-(4-(Trifluoromethoxy)phenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridineIC50250.0 [1], 333.0 [2], 3000.0 [3], 10000.0 [4]
5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamideIC502000.0 [1], 7340.0 [2], 7440.0 [3], 32820.0 [4]
3-Cyano-4-[2-(2-methylpyrazol-3-yl)phenoxy]-N-(1,3-thiazol-2-yl)benzenesulfonamideIC5010000.0 [1], 30000.0 [2]
[3-(Dimethylamino)-4-methoxyphenyl]-(7-methoxyspiro[5H-pyrrolo[1,2-a]quinoxaline-4,4'-piperidine]-1'-yl)methanoneIC50351.0 [1], 572.0 [2], 10485.0 [3]
4-[2-Methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)quinazoline-7-sulfonamideIC5016000.0 [1], 30000.0 [2]
5-Chloro-2-fluoro-4-[(4-hydroxycyclohexyl)methylamino]-N-(1,3-thiazol-2-yl)benzenesulfonamideIC50156.0 [1], 380.0 [2], 730.0 [3], 1300.0 [4]
2-[(3-Methyl-1,2,4-oxadiazol-5-yl)methyl]-6-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[4,3-a]pyridin-3-oneIC501330.0 [1], 1900.0 [2], 10000.0 [3]
LamotrigineIC5039810.72 [1], 62000.0 [2], 100000.0 [3]
TetracaineIC50200.0 [1], 530.0 [2], 650.0 [3]
PropafenoneIC501190.0 [1], 3300.0 [2], 5000.0 [3]
MexiletineIC5013000.0 [1], 58000.0 [2], 420000.0 [3]
DofetilideIC50300000.0 [1], 316227.77 [2], 630957.34 [3]
CID 46840946IC5011.0 [1], 10000.0 [2], 25000.0 [3]
N-[2-Methyl-3-[[4-[4-[[4-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]-1,3,5-triazin-2-yl]amino]phenyl]acetamideIC501100.0 [1], 5200.0 [2], 10000.0 [3]
Nav1.7-IN-3IC502.2 [1], 30000.0 [2]
CID 118734430IC505000.0 [1], 10000.0 [2]
CID 118734436IC505000.0 [1], 10000.0 [2]
CID 118734482IC50400.0 [1], 2300.0 [2]
CID 118734547IC505000.0 [1], 8800.0 [2]
4-(1-Adamantylmethoxy)-5-chloro-2-fluoro-N-methylsulfonylbenzamideIC501070.0 [1], 1900.0 [2]
4-[2-Methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)-2,3-dihydro-1,4-benzoxazine-7-sulfonamideIC501990.0 [1], 2000.0 [2]
2-N-[4-(4-Chlorophenoxy)phenyl]-1,3,5-triazine-2,4-diamineIC50200.0 [1], 3200.0 [2], 10000.0 [3]
N-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamideIC5019000.0 [1], 69000.0 [2], 100000.0 [3]
N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamideIC50920.0 [1], 14800.0 [2], 36000.0 [3]
2-N-[4-[4-(Trifluoromethoxy)phenoxy]phenyl]pyrazine-2,6-diamineIC501260.0 [1], 1500.0 [2], 10000.0 [3]
PhenytoinIC5049000.0 [1], 100000.0 [2]
SildenafilIC50501187.23 [1], 1258925.41 [2]
QuinidineIC506900.0 [1], 16600.0 [2]
MoxifloxacinIC5039810.72 [1], 251188.64 [2]
EverolimusIC50199526.23 [1], 630957.34 [2]
SunitinibIC5015848.93 [1], 39810.72 [2]
DasatinibIC50100000.0 [1], 398107.17 [2]
DuloxetineIC507943.28 [1], 15848.93 [2]
NelfinavirIC5079432.82 [1], 501187.23 [2]
TadalafilIC50125892.54 [1], 158489.32 [2]
SitagliptinIC50630957.34 [1], 794328.23 [2]
NilotinibIC501000000.0 [1], 5011872.34 [2]
RaltegravirIC50316227.77 [1], 1584893.19 [2]
DarunavirIC5039810.72 [1], 100000.0 [2]
VardenafilIC50199526.23 [1], 2511886.43 [2]
TolterodineIC506309.57 [1], 31622.78 [2]
NebivololIC506309.57 [1], 7943.28 [2]
MaravirocIC50630957.34 [1], 1000000.0 [2]
DeferasiroxIC5079432.82 [1], 501187.23 [2]
PaliperidoneIC5025118.86 [1], 158489.32 [2]
EtravirineIC50501187.23 [1], 3981071.71 [2]
AlfuzosinIC50199526.23 [1], 1584893.19 [2]
EltrombopagIC50158489.32 [1], 316227.77 [2]
AmbrisentanIC501000000.0 [1], 1258925.41 [2]
DesvenlafaxineIC50199526.23 [1], 316227.77 [2]
OliceridineIC504700.0 [1], 16500.0 [2]
F-15845 Free baseIC502560.0 [1], 5770.0 [2]
3-(2-Aminopropoxy)-2,4-dimethylphenolIC5030000.0 [1], 174000.0 [2]
AuglurantIC50100000.0 [1]
2,2-Diphenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamideIC509200.0 [1], 10000.0 [2]
(2S)-2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,51S,54S,57S,60R,65R,68S,71S,74S)-27,57-bis(4-aminobutyl)-21-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-24-(3-amino-3-oxopropyl)-54,74-bis(3-carbamimidamidopropyl)-13,51-bis(2-carboxyethyl)-45-(carboxymethyl)-39-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-30,36,68-tris(1H-indol-3-ylmethyl)-71-(2-methylpropyl)-7,33-bis(2-methylsulfanylethyl)-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,67,70,73,76,81-tricosaoxo-4-propan-2-yl-18,19,62,63,78,79-hexathia-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,66,69,72,75,82-tricosazatricyclo[40.34.4.216,60]dooctacontane-65-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acidIC5079.0 [1], 90.0 [2]
2-(2-Amino-1,3-thiazol-4-yl)-N-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]phenyl]acetamideIC5030000.0 [1]
1-[2-Methoxy-4-[3-(trifluoromethyl)phenyl]phenyl]-2-oxo-N-pyrimidin-2-ylquinoline-6-sulfonamideIC5030000.0 [1], 42500.0 [2]
4-[[(3S,4R)-4-(4-Chlorophenyl)piperidin-3-yl]methoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC5010000.0 [1]
CID 118734434IC505000.0 [1]
CID 118734437IC5027000.0 [1]
CID 118734438IC505000.0 [1]
CID 118734439IC505000.0 [1]
CID 118734440IC505000.0 [1]
CID 118734441IC505000.0 [1]
CID 118734442IC505000.0 [1]
CID 118734443IC505000.0 [1]
CID 118734444IC505000.0 [1]
CID 118734445IC505000.0 [1]
CID 118734446IC5020000.0 [1]
CID 118734447IC5020000.0 [1]
CID 118734448IC505000.0 [1]
CID 118734449IC5020000.0 [1]
CID 118734450IC505000.0 [1]
CID 118734451IC504700.0 [1]
CID 118734452IC505000.0 [1]
CID 118734456IC505000.0 [1]
CID 118734458IC505000.0 [1]
CID 118734459IC505000.0 [1]
CID 118734460IC505000.0 [1]
CID 118734461IC505000.0 [1]
CID 118734489IC50500.0 [1], 3500.0 [2]
CID 118734490IC505000.0 [1], 10000.0 [2]
CID 118734548IC505000.0 [1], 10000.0 [2]
1-[2-[3-(4-Benzhydrylpiperazin-1-yl)-2-hydroxypropoxy]-5-fluorophenyl]-3-phenylpropan-1-oneIC505000.0 [1]
1-[2-[2-Hydroxy-3-[4-(4-methylphenyl)piperazin-1-yl]propoxy]phenyl]-3-phenylpropan-1-oneIC505000.0 [1]
Unii-403N302X2YIC5012589.25 [1], 13000.0 [2]
(6S)-N-[4-[[(2S,5R)-5-[(R)-Hydroxy(pyridin-3-yl)methyl]pyrrolidin-2-yl]methyl]phenyl]-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-6-carboxamideIC5030000.0 [1]
1-Methyl-3-[2-(2-methylpyrazol-3-yl)-4-(trifluoromethyl)phenyl]-N-(1,2,4-thiadiazol-5-yl)indole-6-sulfonamideIC5010000.0 [1], 30000.0 [2]
4-[2-(2-Amino-3H-benzimidazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC5010000.0 [1]
4-[2-(3-Amino-1,2-benzoxazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC501000.0 [1], 1380.0 [2]
(4R)-N-[4-[[(2S,5R)-5-[(R)-Hydroxy(pyridin-3-yl)methyl]pyrrolidin-2-yl]methyl]phenyl]-5,6-dihydro-4H-cyclopenta[d][1,3]thiazole-4-carboxamideIC5030000.0 [1]
Tert-butyl 2-amino-4-[3-(1H-indole-2-carbonylamino)phenyl]imidazole-1-carboxylateIC5030000.0 [1]
3-Cyano-4-[2-[2-[(2-piperidin-4-ylethylamino)methyl]pyridin-4-yl]-4-[3-(trifluoromethyl)phenyl]phenoxy]-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC502000.0 [1], 12797.25 [2]
1-[2-Methoxy-4-(trifluoromethyl)phenyl]-2-oxo-N-(1,3-thiazol-2-yl)quinoline-6-sulfonamideIC5030000.0 [1]
CID 127045799IC505000.0 [1], 10000.0 [2]
CID 127045811IC505000.0 [1], 10000.0 [2]
CID 127046243IC505000.0 [1], 10000.0 [2]
CID 127046252IC505000.0 [1], 15900.0 [2]
CID 127046253IC501000.0 [1], 3500.0 [2]



References

This online tool may be cited as follows

MLA

"Quest Database™ Sodium channel protein type V alpha subunit Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Nov2024https://www.aatbio.com/data-sets/sodium-channel-protein-type-v-alpha-subunit-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 21). Quest Database™ Sodium channel protein type V alpha subunit Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/sodium-channel-protein-type-v-alpha-subunit-inhibitors-ic50-ki.
BibTeXEndNoteRefMan